Biocare Medical’s Post

🦴 As we recognize Sarcoma/Bone Cancer Awareness Month, it's crucial to shine a light on key markers in clinical and research that play roles in our understanding of this disease. PRAME (Preferentially Expressed Antigen in Melanoma) is a cancer-testis antigen that has gained significant attention for its diagnostic utility in immunohistochemistry (IHC) diagnostics. Here’s an overview of its diagnostic utility: ✨While generally used in Melanoma differentiation and prognostics, PRAME also has utility in germ cell tumors and its detection can aid in the diagnosis and characterization of tumors in Sarcomas. ✨PRAME is expressed in a variety of other cancers, including breast, lung, and ovarian cancers. While its expression in these cancers is not as specific as in melanoma, it can still provide useful diagnostic information, particularly in the context of poorly differentiated or undifferentiated tumors. https://lnkd.in/gGMwKhx Let's continue our collective efforts in research, awareness, and support to better understand, prevent, and treat cancer. Knowledge is our best weapon. 💪🎀

🦴 As we recognize Sarcoma/Bone Cancer Awareness Month, it's crucial to shine a light on key markers in clinical and research that play roles in our understanding of this disease. ✨Human herpesvirus 8 (HHV-8) is also known as Kaposi sarcoma-associated herpesvirus (KSHV). It encodes a latent nuclear antigen which is the product of the viral gene ORF73.1 ✨IHC staining for HHV-8 is a valuable tool in confirming the diagnosis of Kaposi's sarcoma, particularly in cases where clinical presentation or histology is inconclusive. ✨HHV-8 is strongly linked to Kaposi's sarcoma, a vascular tumor that can manifest in different forms, including classic, endemic, iatrogenic, and epidemic . Let's continue our collective efforts in research, awareness, and support to better understand, prevent, and treat cancer. Knowledge is our best weapon. 💪🎀 https://lnkd.in/dWjVMp4G Let's continue our collective efforts in research, awareness, and support to better understand, prevent, and treat melanoma. Knowledge is our best weapon. 💪🎀

🔬 Biocare's latest white paper series looks in-depth at The Probing Questions: DNA Probes vs RNA Probes vs cDNA Probes 🧬 🌟Click on the link to download this informational white paper! https://lnkd.in/gHZhcyRv Do you have a white paper suggestion? Comment below with white papers you'd like to see!

Ki-67 - In Stock, Ready to Ship 📦 Ki-67 is a monoclonal (MIB-1 and SP6 Clones) antibody that are intended for laboratory use in the qualitative identification of Ki-67 protein by immunohistochemistry (IHC) in formalin-fixed paraffin-embedded (FFPE) human tissues. The clinical interpretation of any staining or its absence should be complemented by morphological studies using proper controls and should be evaluated within the context of the patient’s clinical history and other diagnostic tests by a qualified pathologist. Ki-67 [MIB-1] Antibody - https://lnkd.in/d9hq6p9s Ki-67 [SP6] Antibody - https://lnkd.in/g248fuEb

🎗️Cancer Survivor Awareness Month This month is Cancer Survivor Awareness Month. We honor those who have faced the immeasurable challenges of a cancer diagnosis and emerged victorious, encouraging others with their stories of faith, hope, and courage. They inspire us with their love, strength, and determination. This month is also a reminder of the progress made in cancer treatments and the ongoing need for diagnostic support and research. Our foundational mission at Biocare is "fighting cancer one slide at a time" and we celebrate this month with the friends and families of those that have conquered or are still fighting this terrible disease. Let’s use this month to amplify the voices of cancer survivors, celebrate their victories, and commit to supporting their journey every step of the way.

Join our Webinar! In the realm of research and spatial biology, the ONCORE Pro X stands out as a top-tier, fully open slide staining system designed to streamline and automate staining processes for Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and In Situ Hybridization (ISH). In this webinar, the Biocare team will demonstrate the capabilities and flexibility of the ONCORE Pro X for Multiplex Immunofluorescence (mIF) applications, utilizing popular assay systems from leading researchers in Spatial Biology. Register for this informative webinar by clicking on the link below https://lnkd.in/gG_XWz6K

Melanoma Awareness Month Spotlight: The role of MART-1/Melan-A cocktail (clones M2-7C10 + M2-9E3) The MART-1/Melan-A cocktail (clones M2-7C10 + M2-9E3) recognizes a protein of 18 kDa, identified as MART-1 antibody (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 antibody recognizes a subcellular fraction found in melanosomes. ✨The antibody labels melanomas and tumors showing melanocytic differentiation. ✨It does not mark neoplasms of epithelial origin, lymphomas or mesenchymal tumors. ✨MART-1 is a useful addition to melanoma panels which are specific to melanocytic lesions. https://lnkd.in/gmBdy5bv Let's continue our collective efforts in research, awareness, and support to better understand, prevent, and treat melanoma. Knowledge is our best weapon. 💪🎀

Melanoma Awareness Month Spotlight: The role of Melan-A (MART-1) As we recognize Melanoma Awareness Month, it's crucial to shine a light on key markers in clinical and research that play roles in our understanding of this disease. ✨Melan-A (MART-1) [A103], is a vital tool in diagnostic immunohistochemistry assays, particularly in the evaluation of melanocytic lesions like melanoma. ✨Its use allows for accurate identification of melanocytic differentiation, aiding in the confirmation of melanoma diagnoses and differentiation from other skin cancers. ✨The Melan-A A103 clone, unlike clones M2-7C10 and M2-9E3, can also aid in the recognition of steroid hormone-producing tumors and may be particularly useful in the diagnosis of adrenocortical carcinoma https://lnkd.in/gd63ijQT Let's continue our collective efforts in research, awareness, and support to better understand, prevent, and treat melanoma. Knowledge is our best weapon. 💪🎀

Join Us in Chicago For ASCO - Booth #31165 May 31 - June 4, 2024 | Chicago, IL We invite you to visit us at booth #31165. Our team of experts will be on hand to provide insights and answer any questions you may have. For a more in-depth discussion, we encourage you to schedule an appointment below. See you there! Click the link below to schedule your live demo. https://lnkd.in/dM8DAf5s